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Edited by Michael R. BubbAbstract Microtubules are polymers of a/b-tubulin participat-
ing in essential cell functions. A multistep process involving dis-
tinct molecular chaperones and cofactors produces new tubulin
heterodimers competent to polymerise. In vitro cofactor A
(TBCA) interacts with b-tubulin in a quasi-native state behaving
as a molecular chaperone. We have used siRNA to silence TBCA
expression in HeLa and MCF-7 mammalian cell lines. TBCA is
essential for cell viability and its knockdown produces a decrease
in the amount of soluble tubulin, modiﬁcations in microtubules
and G1 cell cycle arrest. In MCF-7 cells, cell death was preceded
by a change in cell shape resembling diﬀerentiation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Microtubules (Mts) are polarized polymers of a/b-tubulin
heterodimers participating in a wide range of both essential
and specialized cell functions [1,2]. How Mts accomplish this
variety of functions is far from being completely understood.
These functions are controlled by two major protein groups:
(1) Mt associated proteins (MAPs) that modulate their dy-
namic instability, or regulate transport processes and/or their
organization by connecting them to cellular structures or other
cytoskeleton ﬁlaments [3,4]; (2) molecular chaperones and
tubulin cofactors coordinating Mt biogenesis and recycling
of tubulin heterodimers [5].
The generation of new tubulin heterodimers is a multi-step
process involving several protein tubulin cofactors (TBCs).
Nascent a- and b-tubulin chains ﬁrst interact with prefoldin
that delivers them to the cytosolic chaperonin CCT (Cytoso-
lic-Chaperonin-containing-TCP1). Afterwards, as suggested
by in vitro folding assays tubulins follow two diﬀerent folding
pathways; a-tubulin is captured by cofactor B (TBCB), while
b-tubulin by cofactor A (TBCA) [6,7]. Then cofactors E
(TBCE) and D (TBCD) will capture a- and b-tubulin, respec-
tively. The two pathways converge and a-tubulin, b-tubulin,*Corresponding author. Fax: +351 21 4407970.
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would interact with this complex and upon GTP hydrolysis
assembly competent a/b-tubulin heterodimers are released
[8]. The small G-protein Arl2 appears to play a regulatory role
in this pathway, binding to TBCD and sequestering it [9]. In
Saccharomyces cerevisiae TBCs genes were identiﬁed in mutant
screens for cells that were compromised in Mts-dependent
functions. Yeast TBCs genes are not essential, but their muta-
tions confer an increased frequency of chromosome loss,
hypersensitivity to Mt-disrupting drugs and show genetic inter-
actions with tubulin mutations [10,11].
Rbl2p, the TBCA yeast orthologue, has about 30% identity
to mammalian TBCA and was identiﬁed as a protein capable
of rescuing cells from lethal b-tubulin overexpression, serving
as a reservoir of excess b-tubulin [10]. RBL2(A) is not an essen-
tial gene in yeast but is required for normal meiosis [10]. In the
ﬁssion yeast, Schizosaccharomyces pombe, TBCs genes are
essential except the TBCA orthologue gene, alp31+ [12].
Alp31(A) has about 30% identity to mammalian TBCA and
plays an important role in the maintenance of Mts integrity
and the determination of the cell polarity [12]. This family of
proteins appears to be functionally compatible, since murine
TBCA can complement the Rbl2pA function in S. cerevisiae
[10] and Alp31(A) in S. pombe [12]. TBCA is not required for
in vitro b-tubulin folding [13] consistent with the non-essential
behaviour of Rbl2p(A) and Alp31(A) proteins [10,12]. In vitro
experiments show that TBCA plays a dual role inside of the
cell: on one hand, enhancing the dimerization rate of b-tubu-
lin, and on the other hand, serving as a reservoir of excess
b-tubulin [14]. Overexpression experiments of TBCA and
Rbl2p(A) have failed to demonstrate a clear phenotype [14],
in contrast, overproduction of Alp31(A) results in the disap-
pearance of intact Mts structures associated with cell polarity
defects [12].
TBCA expression was analysed in diﬀerent murine tissues.
TBCA is more abundantly expressed in testis and is progres-
sively upregulated from the onset of meiosis through spermio-
genesis, being more abundant in diﬀerentiating spermatids.
TBCA expression seems to be associated to Mt cytoskeleton
changes andwith b-tubulin processing through spermatogenesis
rather than meiosis [15].
Morphology-based mutant screens have identiﬁed TBCs as
essential players in plant morphogenesis [16]. The Arabidopsis
PILZ group genes encode orthologues of mammalian TBCC,
TBCD, and TBCE, and the associated small G-protein Arl2.
Another gene with related mutant phenotype, KIESEL,blished by Elsevier B.V. All rights reserved.
Table 1
Primer sequences speciﬁc for human TBCA, b-tubulin and HPRT used
in PCRs
Genes Sequences
TBCA* 5 0-GTGAAGCGGTTGGTCAAAG-30
5 0-GCAGTGGTCAAAAATAATGG-30
b-Tubulin* 5 0-GGGGCAGGTAACAACTGGG-30
5 0-GAGGTCAGCATTGAGCTGG-30
HPRT* 5 0-GGCGTCGTGATTAGTGATG-30
5 0-CATTACAATAGCTCTTCAGTC-3 0
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Arabidopsis have given results resembling the mammalian in
vitro tubulin folding pathway model [16]. In contrast with both
yeast strains, in Arabidopsis kis(A) mutants result in embryonic
lethality with less severe phenotype than pilz(C/D/E/Arl2) group
mutants [16,17].
In vivo requirements of mammalian TBCs are still unknown
due to lack of loss-of-function studies. In this work, we show
that mammalian TBCA is essential for cell viability and the re-
sults are discussed in view of soluble tubulin levels and Mt
cytoskeleton alterations and how these may lead to cell death.
*Accession number TBCA (NM_004607); b-tubulin (NM_178014) and
HRPT (NM_000194).2. Materials and methods
2.1. Cell culture
Tumour cell lines HeLa and MCF-7 were cultured in a 5% CO2
humidiﬁed atmosphere at 37 C as exponentially growing sub-conﬂu-
ent monolayers in Dulbeccos modiﬁed Eagles medium (DMEM) with
glutamax (Invitrogen), supplemented with 10% fetal calf serum (Invit-
rogen) and non-essential aminoacids (Invitrogen).
2.2. siRNA design and transfection
TBCA siRNA was designed according to criteria outlined elsewhere
[18]. The target sequence is located in the C-terminal coding region, be-
tween nucleotide positions 334 and 352 (334AGAAGCACGTTTAG-
TACTG352) relative to the ﬁrst nucleotide of the start codon of
TBCA gene [NM_004607]. TBCA siRNA was 21 nucleotides long con-
taining symmetric 3 0 overhangs of two deoxythymidines. The non-
target, ﬂuorescent, stable control siRNA with RISC-free modiﬁcation,
siGlo RISC-free siRNA, was used as a negative control. Both siRNAs
were synthesized by Dharmacon Research, Inc.
Transfections were performed with oligofectamine (Invitrogen) as
speciﬁed by the manufacturer. At 18 h prior to transfection, 2.5 · 104
cells were seeded per well for a 24-well plate or 1 · 105 cells were seeded
per well for a 6-well plate. The ﬁnal concentrations of siRNAs in the
culture media were 100 nM. For transfection, siRNAs and oligofecta-
mine were diluted in Opti-MEM I (Invitrogen).
The dependence of the blebbing phenotype on caspase activities was
investigated in TBCA siRNA transfected HeLa cells using the broad
spectrum caspase inhibitor, Z-VAD-FMK (Bachem). Cells were trea-
ted with 100 lM of Z-VAD-FMK for 1 h before transfection and
the inhibitor was maintained during the whole period of transfection
studied.2.3. RNA extraction and RT-PCRs
Total RNA was extracted using RNeasy micro-kit (Qiagen), accord-
ing to the manufacturers protocol. The RNA was treated with DNase
I (Amersham–Pharmacia Biotech) and reverse transcribed using
SuperScript II (Invitrogen) and oligo(dT)12–18 primer (Amersham–
Pharmacia Biotech). The RT-PCR procedure was adapted from Mea-
dus [19]. The amount of cDNA in each sample was ﬁrst normalized
after non-saturing PCR for HPRT (hypoxanthine guanine phosphori-
bosyl transferase 1-standard internal control) transcripts. 25 ll reac-
tion mixture contained 1.5 mM MgCl2, 0.2 mM dNTPs, 30 pmol of
sense primer (Table 1), 30 pmol of antisense primer (Table 1) and
1 U Taq DNA polymerase (Invitrogen) in the manufacturers buﬀer.
PCR consisted of 5 min at 94 C followed by 28 cycles of 30 s at
94 C, 30 s at 53 C, and 1 min at 72 C, and the reaction was stopped
at 72 C for 10 min. All PCRs were performed on a Mastercycler Per-
sonal (Eppendorf). After separation on 2% agarose (SeaKem) gels, the
images were acquired and digitalized with an Eagle Eye II still video
system (Stratagene). The amount of PCR DNA products was quanti-
ﬁed using the ImageJ software.
2.4. Protein extraction and Western blot analysis
For protein extraction cells were rinsed with PBS, and then lysed in
buﬀer containing 100 mM MES, pH 6.7 (Sigma); 1 mM MgCl2
(Merck); 1 mM EGTA (Sigma); 0.1 mM GTP (Sigma); 0.1% NP-40
(Sigma); 0.2 mM DTT (Sigma) and 0.1 mM PMSF (Sigma), contain-ing a protease inhibitors cocktail. Cellular lysates were removed from
culture plates by scraping and then centrifuged at 14000 · g for 30 min
at 4 C and the supernatants were recovered (post-mitochondrial frac-
tion). Total protein extracts were prepared using the same lysing buﬀer
after the addition of 7.5% of 2-mercaptoethanol (Sigma). Equal
amounts of post-mitochondrial protein extracts, obtained from the
same number of non-transfected cells and cells transfected with TBCA
siRNA and with non-target siRNA, were separated on a 16.5% (w/v)
Tricine–SDS–PAGE [20]. Similarly, equal amounts of total protein ex-
tracts, prepared from the same number of non-transfected cells and
cells transfected with TBCA siRNA, were analysed in 10% (w/v)
SDS–PAGE. Westerns blots were performed accordingly to [21] using
the rabbit polyclonal sera against TBCA (1:5000) [22], the mouse
monoclonal antibody against a-tubulin (1:1000) (clone DM1A, Sig-
ma), the mouse monoclonal antibody against b-tubulin (1:1000) (clone
TUB 2.1, Sigma), the rabbit polyclonal sera against Hsp70 (1:5000)
(Stressgen) and the rabbit anti-PARP polyclonal antibody (1:3000)
(Stressgen). Secondary antibodies against mouse (Jackson ImmunoRe-
search) and rabbit (Zymed) were used at 1:4000 and 1:2000, respec-
tively. The immunostaining was carried out using the ECL technique
(Amersham–Pharmacia Biotech). The molecular mass markers used
were purchased from Amersham–Pharmacia Biotech.
2.5. Transmitted light microscopy
Living HeLa cells were grown in a culture DMEM medium without
phenol red (Invitrogen) and were directly observed by inverted trans-
mitted light microscope (Leica Inverted CCD microscope). The image
acquisition was carried out using a cooled CCD camera and Meta-
Morph Imaging Software (Universal Imaging Corporation). The im-
age processing was performed using ImageJ Software.
2.6. Fluorescence microscopy
Cells processed for ﬂuorescence microscopy were washed twice
with PBS (Invitrogen) and then ﬁxed in 3.7% (w/v) paraformaldehyde
(Merck) in PBS for 10 min at room temperature. Then they were
washed twice with PBS for 5 min and permeabilized during 2 min
using 0.1% (v/v) Triton X-100 (Sigma) in PBS. After rinsing twice
for 5 min in PBS and once in PBS-0.1% (v/v) Tween (Merck) cells
were blocked in 3% (w/v) BSA (Calbiochem) for 15 min. Next, cells
were simultaneous incubated with phalloidin (phalloidin–Tetrameth-
ylrhodamine B isothiocyanate) (1:200) (Sigma) and with the mouse
monoclonal a-tubulin antibody (clone DM1A) (1:200) (Sigma) in
the same solution for 1 h. Samples were washed twice in PBS for
5 min and once in PBS-0.1% (v/v) Tween. Secondary antibody Alexa
Fluor 488-conjugated goat anti-mouse IgG (1:500) (Molecular
Probes) was incubated for 1 h in the same solution. The preparations
were washed twice in PBS for 5 min and once in PBS-0.1% (v/v)
Tween. DNA was stained with DAPI (1 lg/ll, Sigma) in PBS for
1 min. The preparations were washed in PBS and mounted in MOW-
IOL 4-88 (Calbiochem) mounting medium supplemented with 2.5%
(w/v) DABCO (Sigma).
Cells were examined with a ﬂuorescence microscope (Leica
DMRA2) and image acquisition was performed with a cooled
CCD camera and MetaMorph Imaging Software (Universal Imaging
Corporation). The image processing was carried out with ImageJ
Software.
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For the determination of cell cycle distribution, cells were harvested,
washed with PBS and ﬁxed with ice-cold 70% ethanol in PBS. After
that the cells were incubated in PBS with 0.1% (v/v) Triton X-100 (Sig-
ma) and 5 lg/ml of RNase (Roche) for 30 min at room temperature.
50 ng/ml of propidium iodide (Sigma) in PBS-0.1% (v/v) Triton
X-100 was added to the cells for 5 min in the dark at room tempera-
ture. Subsequently, cells were washed in PBS and the cell cycle distri-
bution was analysed on FACSCalibur (Becton–Dickinson, Mountain
View, CA) using Cell Queste software.3. Results
3.1. TBCA knockdown by RNAi leads to cell death in HeLa cells
There are only a few studies reporting the role of TBCA in
vivo [for review 14, 16, 17]. Therefore, not much is known
about its role especially in multicellular organisms that show
larger tubulin gene families and express distinct tubulin iso-
types and show more complex Mt structures. Consequently,
we have investigated the phenotypic eﬀects of TBCA knock-
down in mammalian cell lines by selectively silencing the
expression of the TBCA gene protein using RNAi technology
(see Section 2).
The eﬃciency of siRNA transfection in HeLa cells was esti-
mated using a non-target, non-functional ﬂuorescent labeled
siRNA. The ﬂuorescence was correlated with the functional
siRNA uptake (data not shown). Using this control we ob-
served a transfection eﬃciency of about 90–100%. The non-
target siRNA was also used to check for general non-speciﬁc
eﬀects associated with siRNA delivery and to conﬁrm the se-
quence speciﬁcity of the silencing eﬀect (negative control).
We tested the eﬃcacy of the TBCA siRNA silencing by anal-
ysing the TBCA mRNA and TBCA protein levels (Fig. 1A and
B). Total RNA was extracted from HeLa cells transfected for
48 h with non-target siRNA and with TBCA siRNA and then
analysed by RT-PCR. Semi-quantitative RT-PCR analysis
showed a decrease of steady-state levels of TBCA mRNA in
TBCA siRNA transfected cells in comparison with those
found in cells transfected with non-target siRNA. This indi-
cates that TBCA siRNA promotes the silencing of TBCA gene
(Fig. 1A). The steady-state levels of b-tubulin and HRPT
mRNAs did not signiﬁcantly change in TBCA siRNA trans-
fected cells.
Equal amounts of post-mitochondrial protein extracts of
HeLa cells not transfected and transfected with TBCA siRNA
for 24, 48 and 72 h were analysed by Western blot using a set
of antibodies against TBCA, a- and b-tubulin and Hsp70 (Fig.
1B). Similarly, cells transfected with non-target siRNA for
48 h were also analysed. A decrease in the steady-state levels
of TBCA were detected in TBCA knockdown transfected cells
after 24 h post-transfection. This decrease was also accompa-
nied by a decrease of a- and b-tubulin amounts, whereas
there were no signiﬁcant changes in steady state levels of
Hsp70. In both cases the low levels were maintained until
72 h post-transfection (Fig. 1B).
After transfection of HeLa cells with TBCA siRNA we
investigated the eﬀects of TBCA silencing in cell survival by
studying the cells growth and morphology using transmitted
light microscopy (Fig. 1C). At 24 h post-transfection all cell
samples transfected either with non-target siRNA or TBCA
siRNA present a percentage of dead cells (round detached
cells) similar to that observed for non-transfected cells. After48 and 72 h of transfection with non-target siRNA cells were
still proliferating originating small islands of growing cells with
no changes in their normal shape (Fig. 1C). In contrast, TBCA
siRNA transfected cells exhibited a progressive increase of cell
death, visible by the increasing number of small round de-
tached cells (Fig. 1C). After 72 h of TBCA siRNA transfection
there were practically no living cells (results not shown).
Taken together our results support that TBCA is an essen-
tial gene for human cells since its silencing by speciﬁc
TBCA siRNA leads to cell death between 48 and 72 h after
transfection.3.2. Alterations of microtubule and actin cytoskeleton associated
with TBCA siRNA transfection in HeLa cells
The fact that TBCA is described as being able to enhance
b-tubulin dimerization and to serve as a reservoir of excess
of tubulin [14], lead us to investigate if HeLa cells transfected
with TBCA siRNA would exhibit defects in the cytoskeleton
that correlate with previously observed cell death. Therefore,
we studied the Mt and actin cytoskeletons in HeLa cells trans-
fected with TBCA siRNA for 24 h using ﬂuorescence micros-
copy. Mt cytoskeleton was visualized using an antibody
against a-tubulin whereas actin cytoskeleton was stained with
phalloidin. Fig. 2A reveals that the Mt cytoskeleton of TBCA
siRNA transfected HeLa cells show only subtle alterations
when compared to that of non-target siRNA transfected cells
or cells not transfected. TBCA siRNA transfected cells are re-
duced in size, which makes the analysis of the Mt cytoskeleton
diﬃcult. However, we observed a decrease in Mt amount
simultaneous with a diﬀuse labelling in the periphery of the cell
resembling a partial Mt depolymerization (Fig. 2A, see ar-
rows). These cells also showed a signiﬁcant decrease in the
number of mitotic spindles. Interestingly, the actin cytoskele-
ton was undoubtedly altered, since a clear marginal membrane
blebbing is observed (Fig. 2). This phenotype was a represen-
tative feature of the HeLa cells transfected with TBCA siRNA
because there is a threefold increase of the blebbing phenotype
in HeLa cells transfected with TBCA siRNA (Fig. 2B). The
blebbing phenotype caused by TBCA silencing could be re-
lated with an apoptotic event triggered by the alterations de-
tected in Mt and actin cytoskeleton. Indeed, the blebbing
phenotype can be induced by local actin depolymerization
[23,24] or cross-linking of actin ﬁlaments [24,25] and by disas-
sembly of Mts [26,27]. Recently, the marginal blebbing of
TNF-induced apoptosis was also described like an early micro-
ﬁlament-dependent apoptotic event [28].3.3. TBCA knockdown in MCF-7 cells
To investigate if the blebbing phenotype observed in
TBCA depleted HeLa cells was a consequence of an apopto-
tic event related to caspase-3 activation, we transfected
MCF-7 cells, a caspase-3 defective cell line, with the same
TBCA siRNA [29]. Transfection eﬃciency and eﬃcacy of
TBCA siRNA were performed by experiments similar to
those described for HeLa cells. Total RNA was extracted
from MCF-7 cells transfected for 72 h with non-target siR-
NA and with TBCA siRNA. Semi-quantitative RT-PCR
analysis showed a decrease of steady-state levels of TBCA
mRNA in TBCA siRNA transfected cells, whereas the stea-
dy-state levels of HPRT and b-tubulin mRNAs did not sig-
niﬁcantly change (Fig. 3A).
Fig. 1. TBCA knockdown by RNAi leads to cell death in HeLa cells. After 48 h of transfection total RNA was prepared from HeLa cells transfected
with non-target siRNA and TBCA siRNAs (A). Similarly, post-mitochondrial protein extracts were prepared from HeLa cells not transfected and
transfected for 24, 48 and 72 h with TBCA siRNAs (B). Post-mitochondrial protein extracts were also prepared from HeLa cells transfected with
non-target siRNA for 48 h (B). (A) Semi-quantitative RT-PCR analysis showed a decrease in the steady-state levels of TBCA mRNA in TBCA
siRNA transfected cells in comparison to those in cells transfected with non-target siRNA. The steady-state levels of HPRT and b-tubulin mRNAs
remain constant in these cells. (B) For each time studied, equal amount of post-mitochondrial protein extracts were analysed by 16.5% (w/v) Tricine–
SDS–PAGE followed by Western blot with antibodies directed to TBCA, a-, b-tubulin and Hsp70. Cells transfected for 24 h with TBCA siRNAs
showed a decrease in steady-state levels of TBCA, as well as in the levels of a- and b-tubulin when compared with those in control cells. The low levels
of these proteins are maintained until 72 h post-transfection. Hsp70 protein levels were used as a loading control. The approximate molecular mass of
the proteins are indicated at the left side of the panels. (C) After 24, 48 and 72 h of transfection with non-target and with TBCA siRNAs, HeLa cells
were observed by transmitted light microscopy. Cell death increase was observed upon silencing of TBCA in proliferating HeLa cells. Scale bar
150 lm.
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prepared from not transfected and transfected cells after 24,
48, 72 and 96 h with TBCA siRNA and then analysed by Wes-
tern blot using antibodies against TBCA, tubulin and Hsp70(Fig. 3B). Transfected cells with non-target siRNA for 72 h
were also analysed. In contrary to HeLa cells, a decrease in
the steady-state amount of TBCA protein was only detected
in cells transfected with TBCA siRNA after 48 h. However,
Fig. 2. Phenotype analysis of HeLa cells 24 h after TBCA siRNA transfection, assessed by indirect immunolocalization of tubulin and staining of
actin. (A) After 24 h of siRNA transfection, HeLa cells were processed for immunoﬂuorescence microscopy using the antibody directed to a-tubulin,
the phalloidin stain as a ﬂuorescent probe for F-actin and DAPI as a nucleic acid stain. Merged images are shown at right edge panels. As a control
we used the non-target siRNA. Representative images show that TBCA siRNA transfected cells have subtle changes in Mt cytoskeleton showing at
periphery a diﬀuse staining resembling partial depolymerization (see arrows). Actin cytoskeleton presents a clear marginal blebbing. Scale
bar = 4 lm. (B) The number of cells with and without marginal blebbing was determined in HeLa cells transfected with non-target siRNA and with
TBCA siRNA. Graphic bars show mean values of two independent experiments. In each experiment, 1700 cells were counted. An increase of the
blebbing phenotype associated with TBCA siRNA transfection in HeLa cells is clearly visible.
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tubulin in TBCA siRNA transfected MCF-7 cells until 96 h
post-transfection. During the time course studied the steady-
state levels of Hsp70 continue almost unaltered (Fig. 3B).The cytoskeleton phenotype of TBCA siRNA MCF-7 trans-
fected cells for 48 h was also investigated as described for
HeLa cells (Fig. 3C; I–IV). We chose cells transfected with
TBCA siRNA after 48 h because this corresponds to the time
Fig. 3. TBCA silencing in MCF-7 cells. Phenotype analysis by indirect immunolocalization of tubulin and staining of actin. Total RNA was
obtained from MCF-7 cells 72 h post-transfection with non-target siRNA and TBCA siRNAs (A). Post-mitochondrial protein extracts were
prepared fromMCF-7 cells not transfected and transfected for 24, 48, 72 and 96 h with TBCA siRNAs (B). Also, post-mitochondrial protein extracts
were also prepared from MCF-7 cells transfected with non-target siRNA for 72 h (B). (A) Semi-quantitative RT-PCR analysis showed a decrease of
steady-state levels of TBCA mRNAs in TBCA siRNA transfected cells compared to those found in cells transfected with non-target siRNA. The
steady-state levels of HPRT and b-tubulin mRNAs are constant in these cells. (B) For each time studied, equal amount of post-mitochondrial protein
extracts were separated by 16.5% (w/v) Tricine–SDS–PAGE and analysed by Western blot using antibodies against TBCA, a-, b-tubulin and Hsp70
proteins. Cells transfected with TBCA siRNAs showed a decrease in steady-state levels of TBCA protein at 48 h after transfection, whereas steady-
state levels of a- and b-tubulin proteins only decrease after 96 h post-transfection. Hsp70 protein levels were used as a loading control. The
approximate molecular mass of the proteins are indicated at the left side of the panels. (C) After 48 and 96 h of siRNA transfection, MCF-7 cells were
processed for immunoﬂuorescence microscopy using the antibody directed to a-tubulin (I, III, V and VI) and the phalloidin stain as a ﬂuorescent
probe for F-actin (II and IV). As a control we used the not transfected cells. The images shown are representative of at least four independent
experiments. Comparison with cells not transfected (I and II) and transfected for 48 h with TBCA siRNA (III and IV) shows that transfected cells
have a slight decrease in Mts amount (see arrows) and marginal blebbing was not observed. Scale bar = 6 lm (for I–IV). After 96 h of transfection
with TBCA, siRNA cells were dying (VI, see arrows) or became more ‘‘spindle-like’’ (VI, see arrow heads) when compared with those transfected
with non-target siRNA (V). Scale bar = 90 lm (for V and VI).
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with control cells, MCF-7 cells transfected with TBCA siRNA
seem to have a lower amount of Mts (Fig. 3C; I and III). A
careful analysis of a considerable number of MCF-7 cells
transfected with TBCA siRNA (>1000 cells from three inde-
pendent experiments) showed that this was a subtle feature
in most of them. However, in these cells the absence of mitotic
spindles was clearly observable, as well as the absence of bleb-
bing phenotype. Moreover, until 72 h of post-transfection of
MCF-7 cells, the cell death phenotype was not observed. At
96 h after transfection, we detected an increase in MCF-7 dy-
ing cells (rounded up cells) and in spindle-shaped cells, resem-
bling diﬀerentiated cells, a cell shape modiﬁcation thatprobably precedes cell death (Fig. 3C compare panel V with
panel VI).
The phenotype diﬀerences found between HeLa and MCF-7
cells may be related to the fact that the tubulin levels did not
decrease in MCF-7 cells until 96 h after TBCA siRNA trans-
fection. However, we can not exclude the hypothesis that the
absence of the blebbing phenotype in these cells may be related
with the lack of an active capase-3.
To discriminate between these two hypotheses, we have
investigated if caspase activity was associated with the bleb-
bing phenotype presented by HeLa cells after TBCA knock-
down. For this purpose we treated this cell line, prior to
TBCA siRNA transfection, with Z-VAD-FMK an irreversible
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abolish or reduce the blebbing phenotype of HeLa cells trans-
fected with TBCA siRNA (results not shown). However, we
detected a delay in cell death rate during the transfection time
tested (24–72 h) (Fig. 4A). This observation indicates that
Z-VAD-FMK is active and caspases are involved in cell death.
Additionally, in all the experiments the caspase inhibition by
Z-VAD-FMK was assessed by performing Western blot anal-
ysis of total protein extracts prepared from cells transfected
with TBCA siRNA in the presence or absence of the caspase
activity inhibitor Z-VAD-FMK using the antibody against
the Poly (ADP-ribose) polymerase (PARP). PARP is a nuclear
protein involved in DNA repair and an early marker for apop-
tosis. Upon induction of apoptosis PARP is cleaved by cas-Fig. 4. Inﬂuence of the caspase inhibitor Z-VAD-FMK in the TBCA knockd
for 24, 48 and 72 h with TBCA siRNAs, in the presence or absence of the casp
microscopy (A). In the presence of Z-VAD-FMK a decrease in cell death was
150 lm. To test the inhibitor activity of Z-VAD-FMK equal amounts of to
with TBCA siRNA, in presence and absence of the inhibitor and analysed by
against the nuclear protein PARP, an early marker for apoptosis (B). In HeL
the non-cleaved PARP protein levels are higher than those found in HeLa c
being cleaved. HSP 70 protein levels were used as a loading control. The appr
the panel.pase-3 and caspase-7 [30]. As can be seen from Fig. 4B, in
HeLa cells only transfected with TBCA siRNA the non-
cleaved PARP protein levels are lower (50%) than those
found in HeLa cells transfected with TBCA siRNA and
treated with Z-VAD-FMK. This result indicates that in the
presence of Z-VAD-FMK PARP is not cleaved. These exper-
iments show that in HeLa cells the blebbing phenotype could
not be explained by the presence of an active caspase-3 or
other caspases activity.
3.4. TBCA knockdown results in caspase-7 activation but cell
death occurs essentially by secondary necrosis
The obtained results using the caspase inhibitor Z-VAD-
FMK indicated that TBCA siRNA transfected cells were dyingown phenotype in HeLa cells. HeLa cells not transfected or transfected
ase activity inhibitor Z-VAD-FMK, were observed by transmitted light
observed upon silencing of TBCA in proliferating HeLa cells. Scale bar
tal protein extracts were prepared from HeLa cells transfected for 24 h
10% (w/v) SDS–PAGE, and then Western blotted using the antibody
a cells transfected with TBCA siRNA and treated with Z-VAD-FMK
ells only transfected with TBCA siRNA, indicating that PARP is not
oximate molecular mass of the proteins are indicated at the left side of
Fig. 5. TBCA knockdown by RNAi induces caspase-7 activation.
Equal amount of post-mitochondrial protein extracts from HeLa and
MCF-7 cells transfected with TBCA and with non-target siRNAs for
48 h (A) and for 72 h (B), respectively, were analysed by 16.5% (w/v)
Tricine–SDS–PAGE followed by Western blot using antibodies
speciﬁc against procaspase-7 and Hsp70. Cells transfected with TBCA
siRNAs showed a decrease in steady-state levels of procaspase-7,
indicating an activation of caspase-7. Hsp70 protein levels were used as
a loading control. The approximate molecular mass of the proteins are
indicated at the left side of the panels.
3522 S. Nolasco et al. / FEBS Letters 579 (2005) 3515–3524by apoptotic pathways. To conﬁrm this hypothesis we decided
to check the caspase-7 activation. Post-mitochondrial proteins
extracts of cells transfected with TBCA and non-target siR-
NAs, after 48 h for HeLa cells (Fig. 5A) and after 72 h for
MCF-7 cells (Fig. 5B), were prepared and then analysed by
Western blot. Cells transfected with TBCA siRNAs showed
a decrease in the steady-state levels of procaspase-7, indicating
its activation. However, the simultaneous Annexin-V-FLUO
and PI staining showed that the majority of Annexin-V stained
population of cells were also PI positive (results not shown).
Although, the TBCA knockdown causes cleavage of PARP
protein and also the activation of caspase-7, the observed cell
death seems to occur mainly by necrosis/late apoptosis (sec-
ondary necrosis) [31].
3.5. TBCA knockdown in HeLa and MCF-7 cells results in G1
cell cycle arrest
The observation that MCF-7 cells, 48 and 72 h after trans-
fection with TBCA siRNA, did not possess visible mitoticFig. 6. TBCA knockdown by RNAi in HeLa and MCF-7 cells induces a G1
transfected and transfected with TBCA siRNA after 24 and 72 h, respectively
one of two independent experiments show G1 cell cycle arrest. In each case, 30
not be stained with propidium iodide and analysed by FACS due to emissiospindles prompted us to analyse the cell cycle progression in
these and in HeLa cells by ﬂow cytometry (FACS analysis).
HeLa and MCF-7 cells not transfected and transfected with
TBCA siRNA for 24 and for 72 h, respectively, were ﬁxed
and stained with propidium iodide. For these cells, the cell cy-
cle distribution was established by FACS analysis based on
DNA content. This analysis indicates a G1 cell cycle arrest
in HeLa and MCF-7 cells transfected with TBCA siRNA
(see proﬁles of Fig. 6A and B). FACS analysis also conﬁrmed
the cell shape alteration detected in MCF-7 cells, showing that
these cells have an increased width (data not shown).4. Discussion
Mts assembly is dependent on a tubulin heterodimers pool
competent to polymerize. The production of native tubulin
heterodimers requires a complex folding pathway involving
distinct molecular chaperones (prefoldin and cytosolic chap-
eronin CCT) and cofactors (TBCA-TBCE). We have investi-
gated the eﬀects of TBCA knockdown in mammalian cell
lines, HeLa and MCF-7, by selective TBCA silencing using
siRNA. In both cell lines we observed the occurrence of cell
death, and therefore TBCA is an essential protein for human
cells. Until now, there were no studies of tubulin cofactors
loss-of-function in mammalian cells. It is most likely that in vi-
tro folding assays, where TBCA is not necessary for b-tubulin
folding [13], may not reﬂect the in vivo requirements. If the
most important activity of TBCA is to avoid b-tubulin unfold-
ing to prevent aggregation, a dispensable TBCA function in vi-
tro in the presence of the other cofactors will be expected [13].
This may contrast with the in vivo situation where chaperones
are required to prevent misfolding until the substrate enters
into the next folding complex.
We have investigated if mammalian cell death caused by
TBCA knockdown was correlated with Mt and actin cytoskel-
eton alterations. Our results demonstrated that TBCA siRNA
transfected HeLa cells have Mt cytoskeleton disturbed (Fig. 2).
This may reﬂect the decrease of b-tubulin steady-state levels
detected in this cell line upon transfection that are accompa-cell cycle arrest. DNA content of HeLa (A) and MCF-7 (B) cells not
, was analyzed by ﬂow cytometry (FACS analysis). FACS proﬁles from
000 cells were analysed. Cells transfected with non-target siRNA could
n wavelength incompatibility.
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These results suggest that the ratio between a- and b-tubulin
is strictly regulated in mammalian cells probably through their
folding pathways. In HeLa cells, the alterations observed for
Mt cytoskeleton may be responsible for changes in the actin
cytoskeleton leading to the blebbing phenotype. Interestingly,
the detected Mt alterations resemble those observed in plant
and yeast TBCA mutants [10,12,16,17]. However, the pheno-
type in Arabidopsis kis(A) mutants did not show defects in actin
cytoskeleton [16]. In MCF-7 cell line, slight changes in Mt
cytoskeleton were detected at 48 h post-transfection when the
TBCA protein steady-state levels start to decrease. However,
this decrease was not reﬂected on a- and b-tubulin steady-state
amounts until 96 h after transfection when cells go through
dramatic cell shape alterations, like diﬀerentiation, and initiate
to die. In spite of the diﬀerences between the two cell lines, our
results indicate that the decrease in soluble tubulin amount, as
a consequence of TBCA silence, correlates with cell death. In
both cell lines death is preceded by a G1 cell cycle arrest that
is probably due to the alterations of the Mt cytoskeleton.
There are evidences that the destruction of the Mt cytoskeleton
in interphase cells by itself is suﬃcient to induce G1 cell cycle
arrest [32], which has been also closely related with diﬀerenti-
ation in a variety of distinct mammalian cell types [33,34].
The diﬀerences found between HeLa and MCF-7 cell lines
may be due to distinct intrinsic features and/or to the expres-
sion of distinct b-tubulin isotypes with diﬀerent sensitivities
to the absence of TBCA in these two cell lines.
TBCA silencing in both HeLa and MCF-7 cells induces a de-
crease in steady-state levels of procaspase-7 indicating an acti-
vation of caspase-7, one of the major eﬀectors of apoptotic
death signals [35]. Furthermore, the TBCA knockdown in
HeLa cell line in the presence of the caspase activity inhibitor
(Z-VAD-FMK) caused a delay in cell death and a decrease in
PARP protein cleavage. These results strongly suggest the
involvement of caspase activities in cell death caused by TBCA
silence. However, in both cell lines, Anexin-V and PI staining
indicated that cell death occurs essentially by necrosis/late
apoptosis. A link between apoptosis and necrosis was already
established in neurons where caspase inhibitors could reduce
necrosis [31].
In conclusion, our results clearly show that TBCA is essen-
tial for cell viability in mammalian cells. Even so it is still not
clear how TBCA knockdown aﬀects Mt cytoskeleton, but
probably this is a consequence of a decrease in the pool of
a/b-tubulin heterodimers competent to polymerize.
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